Blueprint Medicines Co. (NASDAQ:BPMC) Shares Sold by Corebridge Financial Inc.
otakuyassine3@gmail.com Corebridge Financial Inc. decreased its holdings in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by...
Blueprint Medicines
Blueprint Medicines (NASDAQ:BPMC) Price Target Raised to $119.00
Blueprint Medicines (NASDAQ:BPMC – Free Report) had its target price boosted by Piper Sandler from...
Blueprint Medicines’ (BPMC) Outperform Rating Reiterated at Wedbush
Wedbush reaffirmed their outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in...